drugset / Trial / NCT04540848

Post Operative Pain Control for Distal Radius Surgery: Does Exparel Injected at the Surgery Site Improve Postoperative Pain Scores at 24 and 48 Hours ?

NCT04540848 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to see if Exparel, used intraoperatively by injecting at the surgical site, followed by a Supraclavicular nerve block with bupivacaine in the recovery room, will provide better pain scores for patients at 24 and 48 hours post operatively than, 1)Bupivacaine Hydrochloride (HCL) injection at the surgical site, with a supraclavicular block in Post-anesthesia care unit(PACU), or 2)a supraclavicular block in PACU without any kind of injection at the surgical site.

Timeline

Start
2021-03-01
Primary completion
2021-11-20
Completion
2021-11-20

Outcome

Outcome not reported

Stopped: “Lack of ability to communicate with the study population”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 20 ml Other
Comparator Bupivacaine Other / unclassified 20 ml —
Comparator Bupivacaine Other / unclassified 50 mg Other
Comparator Bupivacaine Other / unclassified 266 mg Other

Indications

No indication recorded.